PURPLE BIOTECH LTD. (PPBT) Operating income 2016–2023
PURPLE BIOTECH LTD. (PPBT) annual operating income history from SEC filings — each fiscal year as reported.
-$22.3MFY2023 · since FY2016: -$7.2M → -$22.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$22.3M | +1.5% |
| FY2022 | -$22.6M | -26.0% |
| FY2021 | -$17.9M | -42.2% |
| FY2020 | -$12.6M | -76.2% |
| FY2019 | -$7.2M | +8.6% |
| FY2018 | -$7.8M | +34.6% |
| FY2017 | -$12.0M | -66.6% |
| FY2016 | -$7.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PPBT financial trends
PPBT RevenuePPBT Net incomePPBT Net marginPPBT Gross profitPPBT Gross marginPPBT Operating marginPPBT Operating cash flowPPBT Free cash flowPPBT Capital expendituresPPBT Return on equityPPBT Stock buybacksPPBT Dividends paidPPBT Total assetsPPBT Total liabilitiesPPBT Shareholders’ equityPPBT overview →